al-01567 has been researched along with hydantoins in 11 studies
| Studies (al-01567) | Trials (al-01567) | Recent Studies (post-2010) (al-01567) | Studies (hydantoins) | Trials (hydantoins) | Recent Studies (post-2010) (hydantoins) |
|---|---|---|---|---|---|
| 13 | 0 | 2 | 3,404 | 80 | 435 |
| Protein | Taxonomy | al-01567 (IC50) | hydantoins (IC50) |
|---|---|---|---|
| Sigma non-opioid intracellular receptor 1 | Homo sapiens (human) | 0.062 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (63.64) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (18.18) | 29.6817 |
| 2010's | 2 (18.18) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Griffin, BW; McNatt, LG | 1 |
| Hockwin, O; Korte, I; Ohrloff, C; Wegener, A | 1 |
| Chandler, ML; Griffin, BW; McNatt, LG; York, BM | 1 |
| Lou, MF; Mahendroo, PP; Thomas, DM | 1 |
| Dickerson, JE; Garadi, R; Lou, MF; York, BM | 1 |
| Brazzell, RK; Dobbs, RE; McCue, BA; Park, YH; York, BM | 1 |
| Kador, PF; Kinoshita, JH; Sharpless, NE | 1 |
| Eisenhofer, G; Harvey-White, J; Kirk, K; Kopin, IJ; Lamensdorf, I; Nechustan, A | 1 |
| Aitken, DA; Crossley, JA; Dunstan, FD; Nix, AB; Spencer, K; Williams, K | 1 |
| Cartault, F; Cormier-Daire, V; Doray, B; Jacquemont, ML; Laville, JM; Munier, P; Munnich, A; Payet, C; Randrianaivo, H; Vellayoudom, J | 1 |
| Cao, J; Chen, H; Han, F; Hao, X; Huang, Y; Jiang, X; Liu, J; Liu, W; Yang, J; Yin, L; Zhang, H | 1 |
1 review(s) available for al-01567 and hydantoins
| Article | Year |
|---|---|
Aldose reductase inhibitors: a potential new class of agents for the pharmacological control of certain diabetic complications.
Topics: Aldehyde Reductase; Animals; Binding Sites; Blood Glucose; Cataract; Chemical Phenomena; Chemistry; Corneal Diseases; Diabetes Complications; Diabetes Mellitus; Diabetic Angiopathies; Diabetic Nephropathies; Diabetic Neuropathies; Diabetic Retinopathy; Disease Models, Animal; Fluorenes; Galactose; Humans; Hydantoins; Imidazoles; Imidazolidines; Models, Molecular; Naphthalenes; Phthalazines; Rhodanine; Sorbitol; Structure-Activity Relationship; Substrate Specificity; Sugar Alcohol Dehydrogenases; Thiazolidines; Tissue Distribution | 1985 |
10 other study(ies) available for al-01567 and hydantoins
| Article | Year |
|---|---|
Characterization of the reduction of 3-acetylpyridine adenine dinucleotide phosphate by benzyl alcohol catalyzed by aldose reductase.
Topics: Alcohols; Aldehyde Reductase; Aldehydes; Animals; Benzyl Alcohol; Benzyl Alcohols; Benzyl Compounds; Catalysis; Fluorenes; Hydantoins; Kinetics; Lens, Crystalline; NADP; Oxidation-Reduction; Rats; Spectrometry, Fluorescence; Spectrophotometry; Sugar Alcohol Dehydrogenases | 1986 |
[Aldose reductase inhibitor--a new way for preventing diabetic lens changes?].
Topics: Aldehyde Reductase; Animals; Cataract; Diabetes Mellitus, Type 1; Fluorenes; Humans; Hydantoins; Rats; Sugar Alcohol Dehydrogenases | 1986 |
Effects of two new aldose reductase inhibitors, AL-1567 and AL-1576, in diabetic rats.
Topics: Aldehyde Reductase; Animals; Diabetes Mellitus, Experimental; Female; Fluorenes; Humans; Hydantoins; In Vitro Techniques; Kinetics; Lens, Crystalline; Male; Placenta; Rats; Rats, Inbred Strains; Sciatic Nerve; Sorbitol; Sugar Alcohol Dehydrogenases | 1987 |
Dynamic phosphorus-31 NMR study of sugar cataract and its prevention in rat lenses with aldose reductase inhibitors.
Topics: Adenosine Triphosphate; Aldehyde Reductase; Animals; Cataract; Culture Techniques; Fluorenes; Hydantoins; Lens, Crystalline; Magnetic Resonance Spectroscopy; Male; Phosphates; Phosphorylcholine; Rats; Rats, Inbred Strains; Sugar Alcohol Dehydrogenases; Time Factors; Xylose | 1988 |
Glutathione depletion in the lens of galactosemic and diabetic rats.
Topics: Aldehyde Reductase; Aminoisobutyric Acids; Animals; Cell Membrane Permeability; Diabetes Mellitus, Experimental; Fluorenes; Galactitol; Galactosemias; Glutathione; Glutathione Reductase; Hydantoins; Lens, Crystalline; Male; NAD; NADP; Rats; Rats, Inbred Strains; Sorbitol | 1988 |
High-performance liquid chromatographic assay of the aldose reductase inhibitor spiro-(2-fluoro-9H-fluorene-9,4'-imidazolidine)-2',5'-dione (AL01567) in plasma and urine and its pharmacokinetics in humans.
Topics: Adult; Aldehyde Reductase; Chromatography, High Pressure Liquid; Double-Blind Method; Fluorenes; Humans; Hydantoins; Male; Spectrophotometry, Ultraviolet; Sugar Alcohol Dehydrogenases | 1988 |
3,4-Dihydroxyphenylacetaldehyde potentiates the toxic effects of metabolic stress in PC12 cells.
Topics: 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; Antioxidants; Dopamine; Energy Metabolism; Enzyme Inhibitors; Estrogens, Non-Steroidal; Fluorenes; Hydantoins; Isoflavones; Mitochondria; Neurons; Oxidation-Reduction; Oxidative Stress; Parkinson Disease; PC12 Cells; Phenylethyl Alcohol; Rats; Rotenone | 2000 |
The effect of temporal variation in biochemical markers of trisomy 21 across the first and second trimesters of pregnancy on the estimation of individual patient-specific risks and detection rates for Down's syndrome.
Topics: alpha-Fetoproteins; Biomarkers; Chorionic Gonadotropin; Chorionic Gonadotropin, beta Subunit, Human; Down Syndrome; False Positive Reactions; Female; Fluorenes; Gestational Age; Humans; Hydantoins; Odds Ratio; Pregnancy; Pregnancy Trimester, First; Pregnancy Trimester, Second; Pregnancy-Associated Plasma Protein-A; Prenatal Diagnosis; Risk Assessment | 2003 |
Expanding the clinical spectrum of B4GALT7 deficiency: homozygous p.R270C mutation with founder effect causes Larsen of Reunion Island syndrome.
Topics: Adolescent; Adult; Child; Facies; Female; Fluorenes; Founder Effect; Galactosyltransferases; Gene Frequency; Homozygote; Humans; Hydantoins; Male; Middle Aged; Mutation; Osteochondrodysplasias; Pedigree; Phenotype; Sequence Analysis, DNA; Young Adult | 2015 |
ALX4, an epigenetically down regulated tumor suppressor, inhibits breast cancer progression by interfering Wnt/β-catenin pathway.
Topics: beta Catenin; Breast Neoplasms; Disease Progression; DNA-Binding Proteins; Down-Regulation; Epigenesis, Genetic; Female; Fluorenes; Humans; Hydantoins; Serine; Transcription Factors; Wnt Signaling Pathway | 2017 |